Impact of proton pump inhibitors on sustained virologic response in veterans treated with sofosbuvir/velpatasvir for chronic hepatitis C virus: A retrospective cohort study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Pub Date : 2022-04-09 DOI:10.1002/phar.2682

Danielle M Rumph, C. Straley, Jenny L Kolberg, David A. Jacob

引用次数: 0

Abstract

The objective of this study was to determine the clinical relationship between proton pump inhibitor (PPI) use and sustained virologic response (SVR) in patients treated with sofosbuvir/velpatasvir (SOF/VEL) for chronic hepatitis C virus (HCV) infection.

查看原文本刊更多论文

质子泵抑制剂对接受索非布韦/维帕他韦治疗慢性丙型肝炎的退伍军人持续病毒学反应的影响:一项回顾性队列研究

本研究的目的是确定质子泵抑制剂(PPI)的使用与索非布韦/维帕他韦(SOF/VEL)治疗慢性丙型肝炎病毒(HCV)感染患者持续病毒学反应(SVR)之间的临床关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

自引率

0.00%

发文量